Clin2
NCT07582120Likely a fitNot yet recruiting

Psilocybin-Assisted Therapy for Depression

Depression

Treatments studied

Part of Mental health clinical trials.

This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with depression and meet study severity criteria
  • You have a trusted support person who can take you home safely after the dosing day
  • If you can become pregnant, you agree to use two forms of birth control during the study and have a negative pregnancy test
  • You are not currently pregnant, breastfeeding, or planning to become pregnant during the study
  • Your depression medication (if any) must be stable—you cannot be on certain antidepressant types or multiple depression medications

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06512194Recruiting· Phase 2
Psilocybin for depression study

This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.

Edwards, Colorado
NCT07281352Recruiting· Phase 1/Phase 2
Psilocybin therapy for depression

This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.

Los Angeles, California
NCT07566104Not yet recruiting· Phase 2
Group therapy with psilocybin for depression

This study tests whether psilocybin—a psychedelic compound—combined with group therapy can help people with depression. Participants receive guided psilocybin sessions at UCLA and attend group therapy to process the experience.

Los Angeles, California
NCT06072898Recruiting· Phase 2
Psilocybin brain imaging trial for depression

This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.

Toronto, Ontario
NCT07183748Recruiting· Phase 2
Psilocybin microdosing plus therapy for hard-to-treat depression

This trial tests whether taking very small, repeated doses of psilocybin (a substance found in magic mushrooms) along with talk therapy can help people with depression that hasn't gotten better with other treatments. You'll need to stop your current depression medications and avoid drugs or alcohol for the study period.

Beersheba
NCT07479550Not yet recruiting· Phase 2
Psilocybin under anesthesia for depression

This trial tests whether a single dose of psilocybin, given while you are under anesthesia, can help treat major depression. You will be monitored closely during and after the session.

Stanford, California

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.